Therapeutic and diagnostic devices maker, AngioDynamics Inc. ( ANGO) recently received 510(k) approval from the U.S. Food and Drug Administration (FDA) for its BioFlo peripherally inserted central ...

TORONTO, ONTARIO--(Marketwire -09/06/12)- Interface Biologics Inc. (IBI), a privately held commercial stage developer of transformative biomedical-polymer products, is pleased to announce that ...

ANGO has enrolled its first patient under the "PICC Related Obstruction of Flow" (:PROOF) randomized multi-center study at University of Miami Hospital. The study intends to enroll 354 patients at a ...

AngioDynamics has announced it has received FDA clearance for a new peripherally inserted central catheter, according to a news release. The company’s BioFlo peripherally inserted central catheters ...

The origination of the central venous catheter technique is attributed to Werner Forrsmann in 1929, who won a Nobel Prize for Medicine in 1956 for his idea of delivering a drug directly into the heart ...

Angiodynamics Inc. has filed a lawsuit against C.R. Bard Inc., claiming the Murray Hill, N.J.-based company has violated antitrust laws with its catheter tip locators. The lawsuit was filed in the U.S ...

TORONTO, ONTARIO--(Marketwire -09/06/12)- Interface Biologics Inc. (IBI), a privately held commercial stage developer of transformative biomedical-polymer products, is pleased to announce that ...

AngioDynamics Inc. ( ANGO) has commenced a new study to evaluate the efficacy of its BioFlo Peripherally Inserted Central Catheter (PICC) in reducing catheter-related thrombosis. This should boost ...